secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2026-06-05T20:33:33+00:00
Accession:  0001104659-26-071011
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics stockholders elect three directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Laura Brege (87.3M for), Badreddin Edris (64.1M for), Jonathan Root (59.2M for) elected Class II directors.
- KPMG LLP ratified as independent auditor for FY2026 with 99.6M for, 1.1K against, 578K abstain.
- Say-on-pay advisory vote approved: 87.1M for, 3.5M against, 577K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/0001104659-26-071011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465926071011/tm2616953d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer